BMEA vs MSCI · $94.7M cap vs P/E 37, rev $2.86B
Biomea Fusion Inc (BMEA) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
BMEA currently screens at market cap $94.7M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the BMEA and MSCI stock pages for the full models.
Not investment advice.